Medical Cannabis Prescriptions in Australia Have Ballooned Since 2020, Study Finds
While medical cannabis has been legal in the country since 2016, the new study found that over 85% of the total prescriptions given to date have only been issued since January 2020.
Lack of Cannabis Research is Hampering Arthritis Treatments, Review Finds
Many patients with rheumatic disease pain are aware of the benefits of cannabis-based treatments, but research is lagging behind them.
Smoking Cannabis Can Combat Fatigue, Study Finds
It might fly in the face of every common stereotype, but according to new research from scientists at the University of New Mexico, smoking cannabis may actually improve feelings of fatigue.
Cannabis Linked to Heart Disease, But a Soybean Compound May Mitigate Risk, Study Finds
Frequent cannabis users are more likely to have a premature heart attack –a heart attack before the age of 50 – than non-users, according to new research from scientists at Stanford University.
FDA Issues its First Warning Letters on Delta-8 THC
According to the administration, the products were illegally marketed as unapproved treatments for various medical conditions.
Cannabis Poisoning Cases in Pets Have Risen Since Legalization, Study Finds
The number of cannabis poisoning cases reported in Canadian pets has increased significantly since 2018, according to a new study from researchers at the University of Guelph, Ontario.
Over Half of Hemp THC Products are Mislabeled, Report Finds
More than half of hemp-based delta-9 THC products vary substantially from the doses on their labels, new testing has found.
Recreational Cannabis Legalization Reduces Demand for Prescription Drugs, Study Finds
The researchers found that when states legalized cannabis, the volume of prescriptions given out for drugs related to managing pain, depression, anxiety, sleep, psychosis, and seizures all decreased significantly.
New Review Finds Cannabis Could be a Promising Treatment For Multiple Sclerosis
Given that some of marijuana's benefits remained past the six- or twelve-month mark, the review authors recommend that more long-term studies be done on medicinal cannabis formulations for MS.
